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Introduction
Protein targeting and transport across lipid bilayers is a funda-
mental energy-requiring process in all organisms. Up to approx-
imately half of the proteins in an organism’s proteome are 
inserted into or transported across membranes by protein trans-
location systems, or translocons (Schatz and Dobberstein, 1996; 
Wallin and von Heijne, 1998). Most bacterial proteins are trans-
ported using the conserved Sec translocation pathway (de Keyzer 
et al., 2003). However, a distinct set of proteins are transported 
in fully folded and assembled form by the twin-arginine trans-
location (Tat) pathway (Berks et al., 2000; Palmer et al., 2005). 
Tat substrates are characterized by a twin-arginine–containing 
consensus motif (SRRxFLK) present in the N-terminal signal 
peptide of precursor proteins. In Escherichia coli, approximately 
two thirds of Tat substrates contain prosthetic groups, which are 
inserted into the proteins in the cytoplasm (Berks et al., 2005). 
A poorly understood proofreading mechanism prevents transport 
of substrates until they are properly folded and assembled 
(Musser and Theg, 2000; Jack et al., 2005).
The E. coli Tat translocation system contains four identi-
fi ed protein components: TatA, TatB, TatC, and TatE. TatA, 
TatB, and TatE each contain a single N-terminal transmembrane 
domain and a C-terminal cytoplasmic domain; the transmem-
brane domain is followed by an amphipathic helix that could 
preferentially interact with the lipid–water interface (Settles 
et al., 1997; Berks et al., 2000). TatC, which contains part of 
the signal sequence binding site (Alami et al., 2003; Holzapfel 
et al., 2007), has six transmembrane domains with both N and 
C termini facing the cytoplasm (Behrendt et al., 2004; Ki et al., 
2004). Mutational analyses have shown that a functional Tat 
system minimally requires TatB, TatC, and either TatA or TatE 
(Sargent et al., 1998, 1999; Weiner et al., 1998). Thus, TatA and 
TatE are structural and functional homologues.
Three main oligomeric Tat complexes have been found in 
the E. coli periplasmic membrane. TatA forms oligomers from 
<100 kD to >500 kD that have been characterized as ring-like 
structures by electron microscopy (Porcelli et al., 2002; Oates 
et al., 2003, 2005; Gohlke et al., 2005). TatBC oligomers have 
an average molecular mass of 500 kD (McDevitt et al., 2006) 
wherein the TatB/TatC ratio is 1:1 (Bolhuis et al., 2001). 
The average molecular mass of TatABC complexes as estimated 
by gel-fi ltration (Bolhuis et al., 2001; Sargent et al., 2001) and 
blue-native gel electrophoresis (Oates et al., 2005) is 600 kD 
and 370 kD, respectively. TatA is found in large molar excess 
(as much as 20-fold) over TatB and TatC (Bolhuis et al., 
2000), suggesting that the TatA complexes outnumber the TatBC 
complexes. It has been hypothesized that a pore composed of 
TatA oligomers allows the mature domain of the precursor protein 
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Figure 1. Precursor proteins, transport effi ciencies, TatABC expression levels, and membrane orientation in in vitro Tat transport assays. (A) The precursor 
proteins used in the transport assays. The twin-arginine motifs (bold), signal peptidase recognition sequences (underlined) and signal sequence cleavage 
sites (arrow) are identifi ed. Lowercase, italicized letters are residues of the mature SufI and TorA domains that have been retained in the GFP fusions. (B) Purity 
and fl uorescence of the precursor proteins. Purifi ed precursor proteins were visualized in SDS-PAGE gels by Coomassie blue staining (left) and the fl uor-
escence emission upon UV excitation (right). (C) A standard in vitro transport assay. In this anti-SufI immunoblot, known amounts of pre-SufI (lanes 1–4), 
marked as a percentage of the precursor protein (p) added to the transport reactions, allowed quantifi cation of the transport effi ciency. Samples were pro-
teinase K treated after 30 min at 37°C. NADH (4 mM) promoted the appearance of protease-protected mature-length protein (m). Higher molecular weight 
bands result from immuno-crossreactivity with unknown endogenous proteins (see G). Under some conditions, minute quantities of precursor were detect-
able in the absence of NADH; control experiments indicate that this was likely due to incomplete protease digestion, and this amount was always subtracted 
from that observed in the presence of NADH for accurate quantifi cation of transport. Effi cient transport required overexpression of TatABC, and was typi-
cally higher in JM109(pTatABC) than in MC4100(pTatABC), here quantifi ed as 73 and 45%, respectively. Lane 8 was considered standard assay condi-
tions. [pre-SufI] = 50 nM; [IMV] = 5 (A280). (D) Transport effi ciencies of different MC4100-derived strains. This anti-SufI immunoblot demonstrates that 
overexpression of TatABC promoted effi cient protein transport (compare lanes 4 and 8), and that TatD and TatE were not required for effi cient transport 
(compare lanes 6 and 10). Same conditions as panel C. (E) TatABC overexpression. Expression of TatA, TatB, and TatC proteins was induced from the 
pTatABC plasmid in JM109 (J) and MC4100 (M) strains with 0.7% arabinose, as indicated. All three proteins were retained in IMVs. Five microliters of total 
cell extracts (A600 = 4.4) were loaded per lane; 1 μl of IMVs (A280 = 50) was loaded per lane. (F) TatB accessibility assay. The percentage of inside-out ori-
ented vesicles in IMV preparations was determined by the protease accessibility of the TatB cytoplasmic domain. This anti-TatB immunoblot shows different 
amounts of control IMVs for quantifi cation purposes (lanes 1–7), where the 100% lane represents the amount of TatB present before proteinase K (PK) treatment. 
After protease treatment (lane 8), 10% of the original TatB remained, and upon protease treatment in the presence of 0.05% TX-100 (lane 9), all the TatB 
was digested. These data indicate that the vesicles in this IMV preparation were 90% inside-out. (G) Protease digestion of mature SufI after membrane 
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to cross the membrane (Sargent et al., 2001). In such a model, 
the mature domain of a precursor protein bound to a TatBC 
complex through its signal sequence would have to be trans-
ferred through the TatA pore, perhaps as a result of oligomeriza-
tion of a TatBC complex and a TatA complex.
The Tat system was fi rst identifi ed in plant thylakoids as 
a translocation system that requires the proton motive force 
(PMF), and not ATP, for transport. The energy stored in the 
PMF has two components, the electric fi eld gradient (∆ψ) and 
the pH gradient (∆pH). From early experiments on thylakoids, 
it was concluded that the Tat system is energetically driven by 
the ∆pH alone (Mould and Robinson, 1991; Cline et al., 1992). 
This basic conceptual fi nding was recently challenged (Finazzi 
et al., 2003), and more recent work indicates that the ∆ψ can 
also contribute to driving Tat transport in thylakoids (Braun et al., 
2007). Energetic studies of the bacterial Tat machinery have 
been hampered by the lack of an effi cient in vitro assay. The fi rst 
reported in vitro assay yielded a transport effi ciency of <1% 
(Yahr and Wickner, 2001). Subsequently, it was found that pre-
cursors can be transported with up to 20% transport effi ciency 
if they are synthesized via in vitro translation in the presence of 
inverted membrane vesicles (IMVs) (Alami et al., 2002). Here, 
we report the development of an effi cient in vitro assay for the 
E. coli Tat machinery using purifi ed overexpressed precursors. 
We show that two distinct ∆ψ-dependent steps are required for Tat 
transport. We did not detect a role for the ∆pH in infl uencing trans-
port effi ciency, despite the presence of substantial pH gradients. 
Our data are consistent with a model in which a relatively 
large ∆ψ of brief duration is required for an initial step in the 
transport process, and in which a small ∆ψ of long duration is 
required for a later step.
Results
An effi cient in vitro pre-SufI 
transport assay
To avoid the assembly and folding complications inherent 
in using a Tat substrate that contains a cofactor, we have used 
pre-SufI, spSufI-GFP, and spTorA-GFP (Fig. 1 A). Although SufI 
is homologous to proteins of the multi-copper oxidase family, 
SufI does not appear to bind Cu2+ (Stanley et al., 2000) or pos-
sess a cofactor binding site (Berks, 1996). Pre-SufI was isolated 
under native conditions. The artifi cial GFP substrates were iso-
lated under denaturing conditions and folded in vitro. Proper 
folding of the GFP substrates was assumed based on their green 
fl uorescence emission upon UV excitation (Fig. 1 B).
A typical in vitro transport assay consisted of the addition 
of TatABC-enriched IMVs to prewarmed (37°C) tubes containing 
50 nM pre-SufI. NADH was used to generate a PMF. Reactions 
were incubated at 37°C for 30 min and then treated with protease 
(proteinase K) to digest any remaining untransported pre-SufI. 
The proteins in each reaction were resolved by SDS-PAGE 
and immunoblotted using SufI antibodies (see Materials and 
methods). Overexpression of TatA, TatB, and TatC was essential 
for detecting transport, and only these three Tat proteins were 
required (Fig. 1, C–E). In general, IMVs from JM109 were 
easier to work with and yielded better transport effi ciencies than 
those from MC4100 (Fig. 1 C). Membrane orientation in vesicle 
preparations was estimated by the accessibility of the TatB 
cytoplasmic domain to protease digestion. Typical membrane 
preparations consisted of 90% IMVs and 10% right-side-
out vesicles (Fig. 1 F). Addition of 0.05% Triton X-100 during 
protease treatment resulted in complete digestion of mSufI 
(Fig. 1 G), indicating that pre-SufI that had translocated into the 
vesicle lumen could be digested by protease after membrane 
permeabilization. Control experiments lacking added pre-SufI 
demonstrate that the high molecular weight bands observed on 
anti-SufI immunoblots arose from endogeneous proteins within 
the IMV preparations, and not from pre-SufI aggregates (Fig. 1 G, 
lanes 4 and 7). Detection with 6xHis antibodies confi rms this 
result (Fig. 1 H). Mature- and precursor-length SufI were not 
always resolvable due to their small difference in molecular 
weights (e.g., compare Fig. 1, C, G, and H).
Transport of GFP fused with TorA and SufI 
signal peptides
Having developed an effi cient in vitro Tat transport assay, we 
then tested whether a common model substrate, spTorA-GFP 
(Santini et al., 2001; Thomas et al., 2001; DeLisa et al., 2004), 
could be effi ciently transported under the conditions that yielded 
effi cient pre-SufI transport. The spTorA-GFP protein was trans-
ported at a much lower effi ciency (up to 15%; Fig. 2 A) than 
pre-SufI (72 ± 7%). We considered the possibility that proteins 
with the TorA signal peptide could not be effi ciently transported 
in our standard assay for unknown reasons. Therefore, we changed 
the signal peptide on spTorA-GFP to that of pre-SufI yielding 
spSufI-GFP (Fig. 1 A). No transport of spSufI-GFP could be 
detected (Fig. 2 B).
spTorA-GFP is a competitive inhibitor for 
pre-SufI transport
We expected that protein chimeras containing Tat signal pep-
tides should at least interact with the signal peptide binding site 
of the Tat translocation machinery. If so, such chimeras should 
competitively inhibit transport of pre-SufI. Surprisingly, even 
a 50-fold molar excess of spSufI-GFP had no effect on transport 
of pre-SufI (Fig. 2 C). These data indicate that spSufI-GFP can-
not bind (or only very weakly binds) to the Tat pathway receptor 
complex. In contrast, pre-SufI transport was almost completely 
inhibited by a 10-fold molar excess of spTorA-GFP (Fig. 2 D). 
These data likely indicate that spTorA-GFP was recognized by 
the Tat translocation machinery through the TorA signal peptide, 
permeabilization. The left anti-SufI immunoblot shows that addition of 0.05% Triton X-100 (TX-100) during proteinase K (PK) treatment under standard assay 
conditions (see panel C) resulted in complete loss of the mature SufI protein band (compare lanes 9 and 12). The right anti-SufI immunoblot shows that 
PK addition resulted in complete digestion of pre-SufI. (H) Same experiment as panel G, but using 6xHis antibodies. Due to the lower detection effi ciency 
of the 6xHis antibodies, samples were sedimented and gel loads (based on IMV amount) were 16 times higher than in panel G.
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and therefore, that spTorA-GFP competitively inhibited pre-
SufI transport.
Transport kinetics
Having established optimum conditions for pre-SufI transport, we 
then examined the transport kinetics. Transport reactions were 
quenched at various times by plunging reaction tubes into an ice 
bath. Two notable features were immediately apparent: (1) trans-
port was a relatively lengthy process, occurring on the timescale of 
many minutes; and (2) the transport kinetics were complex (i.e., 
not a single exponential), exhibiting a lag period before the ap-
pearance of transported protein (Fig. 3). A lag period was observed 
earlier for the thylakoid Tat system (Musser and Theg, 2000).
Tat transport is completed in the absence 
of a detectable PMF
When NADH is added to IMVs, the electron transport chain 
generates a PMF using dioxygen (O2) as the fi nal electron 
 acceptor. Thus, the duration of the resultant pH gradient and elec-
trical potential is limited by how rapidly the dissolved oxygen is 
consumed. Steady-state fl uorescence spectroscopy was used to 
monitor the presence of a ∆pH and a ∆ψ (see Materials and 
methods). Because the detectable gradients (as reported by the 
dyes) decayed in seconds to tens of seconds after oxygen con-
sumption, the duration that detectable gradients existed (∆pHd 
and ∆ψd) was somewhat longer than the time to anaerobiosis 
(∆pHt and ∆ψt), although the latter were more easily measur-
able due to discrete infl ection points. ∆pHt and ∆ψt were identi-
cal (within error) for a given set of conditions; ∆pHd and ∆ψd 
were not identical. At least part of these differences can be at-
tributed to the inherent slow response of the dye distributions to 
the gradients. As expected, both ∆pHt and ∆ψt were inversely 
affected by an increase in IMV concentration, consistent with 
a faster enzymatic consumption of dissolved oxygen at higher 
IMV concentrations (Fig. 4, A and B). At the concentration 
of TatABC-enriched IMVs used in our standard transport as-
say (A280 = 5), the solutions became anaerobic in 10 ± 4 s 
(Fig. 4, C and D), and detectable ∆pH and ∆ψ gradients were 
observed for 15 s and 10 s, respectively (Fig. 4, A and B). 
Figure 2. Transport of spTorA-GFP and spSufI-GFP and their ability to 
compete for transport with pre-SufI. (A) Transport effi ciency of spTorA-GFP. 
This anti-GFP immunoblot shows that transport of spTorA-GFP (50 nM) in 
the presence of 4 mM NADH requires TatABC overexpression. Based on 
known amounts of spTorA-GFP (lanes 1–4), the transport effi ciency of this 
precursor in this experiment was 15%. Because proteinase K (PK) treat-
ment digests the precursor only to a mature-sized fragment, reactions were 
sedimented before running the gel. Mature-length protein generated by PK 
treatment was lost due to this sedimentation procedure (lane 14). Thus, the 
mature-length protein observed in lanes 8 and 12 was generated by trans-
port into the vesicle lumen. The protein present in lane 13 represents the 
amount of precursor-length protein that aggregated or bound to the walls 
of the reaction tube. Siliconized tubes were used to minimize adsorption of 
precursor to the walls of the tubes. (B) Transport effi ciency of spSufI-GFP. 
This anti-GFP immunoblot shows that transport of spSufI-GFP (50 nM) was 
undetectable. Experiments were performed identically to those in panel A. 
(C) Competition between spSufI-GFP and pre-SufI. This anti-SufI immuno-
blot shows the pre-SufI transport effi ciency under standard conditions 
(Fig. 1 C) in the presence of a 0- to 50-fold molar excess of spSufI-GFP. 
IMVs were preincubated with both precursor proteins for 10 min at 37°C 
and transport reactions were initiated with 4 mM NADH. (D) Competition 
between spTorA-GFP and pre-SufI. Transport reactions were performed 
identically as in panel C, except that spTorA-GFP was used instead of 
spSufI-GFP.
Figure 3. Transport kinetics. All assays were conducted under standard 
transport conditions (Fig. 1 C). Reactions were initiated with IMVs and 
quenched in an ice bath (n = 7). The transport effi ciency is scaled relative 
to the amount of precursor added.
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However, mature SufI continued to accumulate for at least 
12 min after the reaction became anaerobic (Fig. 3), indicating 
that Tat pathway–mediated transport of precursor proteins can 
be completed in the absence of a detectable ∆pH and ∆ψ.
We next tested whether the duration of the detectable ∆pH 
and ∆ψ infl uenced pre-SufI transport effi ciency by varying the 
concentration of the IMVs. As the IMV concentration was de-
creased from A280 = 5 to A280 = 0.5, the ∆ψt and ∆pHt increased 
from 10 s to 42 s (Fig. 4, C and D). At a high precursor con-
centration (presumably saturating the Tat translocons over all 
the IMV concentrations tested), the amount of precursor trans-
ported per IMV was invariable (Fig. 4 E). These data indicate 
that the approximately fourfold increase in the duration of the 
detectable ∆ψ and ∆pH did not affect pre-SufI transport effi -
ciency under these conditions.
The 𝚫𝛙 alone provides the energetic driving 
force for pre-SufI transport
We next examined the effect of the magnitude of the detect-
able ∆ψ and ∆pH on pre-SufI transport effi ciency. Because ∆pH 
generation takes many seconds due to the large number of ions 
that must be translocated, the point at which the maximum ∆pH 
(∆pHm) was generated was easily estimated (Fig. 5 A). In con-
trast, ∆ψ generation is very fast due to the much lower number of 
ions that must be translocated, and it was not always clear if ob-
served signals were due to the injection needle, mixing artifacts, 
or ∆ψ generation. Instead, we estimated the average ∆ψ (∆ψavg; 
Fig. 5 B). We compared the pre-SufI transport effi ciencies ob-
tained with various uncoupler concentrations. When the ∆pH 
was selectively reduced with various concentrations of nigericin 
(an electroneutral K+/H+ exchanger), pre-SufI transport was 
unaffected or slightly increased. Increased transport effi ciencies 
correlated with an increased ∆ψavg (Fig. 5 C). When the ∆ψ was 
selectively reduced with valinomycin (a K+ ionophore), the 
∆pHm remained high and transport effi ciency again correlated 
with ∆ψavg (Fig. 5 D). The ∆ψ could not be completely dissi-
pated with valinomycin alone (see Fig. S3 for an explanation, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200702082/DC1). 
However, in the presence of both valinomycin and nigericin, 
the detectable ∆pH and the ∆ψ were both completely collapsed 
and pre-SufI transport was completely inhibited (Fig. 5 E). 
For complete dissipation of the ∆ψ by valinomycin (at A280 = 5), 
a low concentration of nigericin was necessary (Fig. 5 B). When 
the detectable ∆pH was fi rst completely dissipated by a low 
concentration of nigericin and the ∆ψ was progressively dissi-
pated by increased concentrations of valinomycin, the pre-SufI 
transport effi ciency was highly correlated with ∆ψavg (Fig. 6 A).
When the ∆ψ was dramatically reduced by 25 mM NaSCN 
Figure 4. Duration of the detectable PMF and its effect on pre-SufI transport yield. (A) ∆pHt dependence on the IMV concentration. ∆pH generation was 
measured by quinacrine fl uorescence in the presence (red) and absence (black) of 10 μM nigericin at the indicated IMV concentrations. The time span 
between NADH (4 mM) addition (20 s time point; identifi ed by the open arrowhead) and the time at which the next infl ection point occurred (identifi ed by 
the fi lled arrowhead), presumably the point at which the solution became anaerobic, was termed the ∆pHt. The time span between NADH addition and 
the time at which the detectable gradient ceased to exist was termed the ∆pHd. (B) ∆ψt dependence on the IMV concentration. ∆ψ generation was measured 
by oxonol VI fl uorescence in the presence (red) and absence (black) of 10 μM nigericin and 10 μM valinomycin at the indicated IMV concentrations. 
∆ψt and ∆ψd were defi ned similarly to ∆pHt and ∆pHd in (A), respectively, as indicated. (C) Mean ∆pHt plotted against the IMV concentration (n = 3). (D) Mean 
∆ψt plotted against the IMV concentration (n = 3). (E) Dependence of transport yield per vesicle on vesicle concentration. Transport yield per vesicle was 
measured at a high pre-SufI concentration (250 nM) at various IMV concentrations (n = 3). A measure of the transport yield per vesicle was obtained by 
dividing the transport yield (pmol pre-SufI) by the IMV concentration (A280). Though not the actual transport yield per vesicle, these values are expected to 
be directly proportional to the true values.
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without decreasing the ∆pH gradient (Fig. 5, A and B), pre-SufI 
transport was almost completely inhibited (Fig. 6 B). Transport 
reactions with spTorA-GFP confi rmed the pre-SufI results that 
Tat transport requires a ∆ψ (Fig. 6 C). The increased spTorA-
GFP transport observed when nigericin was present (Fig. 6 C) 
is likely explained by the increased ∆ψavg observed under these 
conditions (Fig. 5, B and C), which likely results from compen-
sation for the PMF decrease that results from loss of the ∆pH. 
The NaSCN data support the hypothesis that inhibition of pre-
SufI transport by valinomycin was through collapse of the ∆ψ, 
rather than by a direct effect of valinomycin on the Tat trans-
location machinery. In total, these data indicate that pre-SufI 
transport was largely, if not completely, independent of the ∆pH 
and strongly dependent on the ∆ψ.
A long duration, undetectable 𝚫𝛙 is 
required for pre-SufI transport
The data discussed in the previous two sections indicate that 
pre-SufI transport required a ∆ψ, yet transport occurred on a 
much longer timescale (many minutes) than the time a detect-
able ∆ψ (10 s) was maintained across IMV membranes. 
One possible explanation for these results is that the ∆ψ is required 
only for an early step in the transport process and that later steps 
of transport do not require a ∆ψ. To investigate this possibility, 
we added ionophores to dissipate any nonmeasurable gradients 
at various times after reaction initiation. As expected based on 
earlier results (Fig. 5 and Fig. 6), pre-SufI transport effi ciency 
was not affected by dissipation of the ∆pH by 10 μM nigericin 
either early or late in the transport process (Fig. 7 A). In con-
trast, addition of 10 μM nigericin and 10 μM valinomycin early 
in the transport process (e.g., at 1–5 min after reaction initiation) 
almost completely inhibited pre-SufI transport (Fig. 7 B), de-
spite the fact that the detectable gradients had collapsed when 
the ionophores were added (Fig. 4, A and B). Our interpretation of 
these data is that undetectable ∆pH and ∆ψ gradients existed 
after the reaction solutions became anaerobic. One possibility is 
that the solutions were not completely anaerobic due to gas ex-
change at the aqueous–air interface, thereby allowing low level 
respiratory activity. Alternatively, a small ∆ψ was maintained 
by an anaerobic pathway. Regardless, our interpretation of these 
data is that a small, undetectable ∆ψ was maintained after col-
lapse of the short duration but substantial ∆ψ spike (Fig. 4 B), 
Figure 5. Pre-SufI transport effi ciency dependence on 𝚫pHm and 𝚫𝛙avg. (A) Determination of the ∆pHm under various conditions. The ∆pH was measured 
as in Fig. 4 A by the addition of 4 mM NADH (open arrowhead). The ∆pHm was defi ned to be the difference between the baseline after the solution became 
anaerobic and the minimum fl uorescence observed. [IMV] = 5 (A280). (B) Determination of the ∆ψavg under various conditions. The ∆ψ was measured as in 
Fig. 4 B. The ∆ψavg was defi ned to be the area bounded by the fl uorescence curve and the extrapolated baseline after the solution became anaerobic be-
tween the point of reaction initiation and the point at which the detectable gradient disappeared. Note that the time axes are different in panels A and B. 
[IMV] = 5 (A280). (C) Effect of nigericin on ∆pHm, ∆ψavg and pre-SufI transport effi ciency. Values are given as mean ± SD (n ≥ 3), where 100% = the values 
obtained in the absence of ionophores. (black) ∆pHm; (red) ∆ψavg; (blue) pre-SufI transport effi ciency. (D) Effect of valinomycin on ∆pHm, ∆ψavg and pre-SufI 
transport effi ciency. Same key as panel C. (E) Effect of nigericin and valinomycin on ∆pHm, ∆ψavg and pre-SufI transport effi ciency. Both ionophores were 
always present at the same concentration. Same key as panel C.
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 after addition of NADH. Effi cient Tat transport (> 90% of 
 control) occurred even if pre-SufI was added up to 5 min after 
membrane energization, long after collapse of the short, initial ∆ψ 
spike (Fig. 7 C). Transport effi ciency decreased by 90% with an 
30 min delay between precursor addition and membrane ener-
gization (Fig. 7 C), possibly due to consumption of NADH.
A second 𝚫𝛙 spike increases transport yield 
only after a time delay
Because effi cient pre-SufI transport resulted when the precursor 
was added after collapse of the ∆ψ spike, we considered the 
possibility that the undetectable ∆ψ gradient was suffi cient to 
drive the entire Tat translocation cycle. To test this hypothesis, 
we measured the translocation yield after producing a second 
∆ψ spike by addition of O2-saturated buffer. We observed that 
the pre-SufI translocation yield increased by 60% when a 
second ∆ψ spike was generated 12.5–20 min after the fi rst. 
A second ∆ψ spike had little to no effect if it was generated 
< 5 min after reaction initiation (Fig. 8, A and B).
The transport kinetics are similar over 
a range of IMV concentrations
The fact that a second ∆ψ spike generated within 5 min of the 
fi rst had little to no infl uence on transport yield indicates that the 
translocons were predominantly at a stage in the precursor trans-
location cycle where the energy of the second ∆ψ spike could not 
be used. This suggested to us that perhaps the kinetics shown in 
Fig. 7 B refl ected a single translocon turnover cycle, and that 
a ∆ψ spike might be required to initiate a second turnover cycle. 
To test this possibility, we reasoned that the observed kinetics 
should be essentially invariable with IMV concentration if they 
reported a single translocation cycle. In contrast, if the kinetics in 
Fig. 7 B refl ected numerous enzyme turnovers, we reasoned that 
faster transport would be observed at higher IMV concentrations. 
We observed that the transport kinetics were largely independent 
of IMV concentration (Fig. 8 C). According to the predictions 
just discussed, these data are consistent with the picture that the 
observed transport kinetics refl ect a single turnover cycle.
spTorA-GFP can competitively inhibit 
pre-SufI transport long after transport 
initiation
Considering the conclusion from the previous section that the 
transport kinetics are consistent with a single turnover cycle, 
we hypothesized that if spTorA-GFP was added after pre-SufI 
transport was initiated, it might no longer be competitive for 
transport. We found that pre-SufI transport was sensitive to the 
addition of spTorA-GFP competitor more than 5 min after re-
action initiation. In fact, the transport inhibition versus the time 
delay of competitor addition curve (Fig. 9) looks surprisingly 
similar to the transport kinetics of the reaction as determined by 
ionophore quenching (Fig. 7 B).
Translocation speed is dependent on the 
magnitude of the steady-state 𝚫𝛙
To maintain a high magnitude steady-state ∆ψ, ATP was used to 
generate a PMF through catalytic reversal of the F0F1 ATPase. 
Figure 6. Effect of selective 𝚫𝛙 and 𝚫pH gradient collapse on pre-SufI 
and spTorA-GFP transport effi ciency. (A) Correlation between ∆ψavg and 
pre-SufI transport effi ciency. This anti-SufI immunoblot shows standard 
transport assays (Fig. 1 C) with different concentrations of nigericin (Nig.) 
alone (lanes 6–8), or with both nigericin and valinomycin (Val.) (lanes 11–14). 
The control reaction (lane 4) had no NADH added. Transport effi ciency 
was calculated based on the transport observed in the absence of iono-
phores (lanes 5 and 9). Same key as Fig. 5 C. (B) Effect of selective 
 gradient collapse on pre-SufI transport effi ciency. This anti-SufI immunoblot 
shows standard transport assays with 10 μM nigericin (N), 10 μM valino-
mycin (V), and/or 25 mM NaSCN (S) added before reaction initiation (0) 
or 30 s after reaction initiation (30 s), as indicated. The control reactions 
(C) had no uncouplers. Values are given in the bar graph as mean ± SD 
(n = 3). Transport effi ciency was calculated based on the transport ob-
served in the absence of uncouplers (lane 6). (C) Effect of selective gradient 
collapse on spTorA-GFP transport effi ciency. The same experiment as panel B 
using spTorA-GFP instead of pre-SufI.
and that this undetectable ∆ψ was essential for driving pre-SufI 
transport. The threshold sensitivity of our ∆ψ measurements is 
unknown. Other investigators have estimated a threshold sensi-
tivity of 50 mV, but this value is strongly dependent on the 
lipid to dye ratio (Ghelli et al., 1997).
Effi cient transport does not require the 
precursor protein to be present during 
the 𝚫𝛙 spike period
To address whether a precursor protein must be present during the 
∆ψ spike period, pre-SufI was added to IMVs at various times 
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With this approach, the ∆ψ is independent of the dissolved 
O2 concentration and depends only on the ATP energy charge. 
Because ATP can be solubilized at higher concentrations than 
O2 and regenerated in situ, the ∆ψ gradient can be maintained 
for a longer period. When ATP (plus an ATP regenerating system) 
was used to energize IMVs, both ∆pH and ∆ψ remained detect-
able for at least 9 min (Fig. 10, A and B), and pre-SufI trans-
location was approximately threefold faster (Fig. 10 C) without 
the detectable lag phase observed when IMVs were energized 
by NADH (Fig. 7 B). Despite the ability of ATP to establish a 
long-lived high-magnitude ∆pH, pre-SufI transport was, once 
again, largely, if not completely, independent of the ∆pH and 
strongly dependent on the ∆ψ (Fig. 10D). These data support 
the hypothesis that translocation speed is dependent on the 
magnitude of the steady-state ∆ψ. When NADH was used to 
generate a PMF, the length of the lag period was observed to 
vary for different IMV preparations (not depicted). In light 
of the above ATP results, we surmise that the length of the lag 
period refl ects the differential ability of different IMV prepara-
tions to support a ∆ψ.
Discussion
The development of an effi cient in vitro transport assay for the 
E. coli Tat machinery has allowed us to decipher a number of 
important fundamental features of the transport mechanism: 
(1) the energetic driving force for transport comes largely, if not 
entirely, from the ∆ψ alone—we have no evidence that the ∆pH 
assists with promoting transport (Figs. 5, 6, and 10); (2) at least 
two distinct transport steps require a ∆ψ—one ∆ψ requiring 
step occurs early in the transport process and requires a ∆ψ of 
relatively high magnitude that may be short-lived (Fig. 8, A and B), 
and a second ∆ψ requiring step minimally requires a long dura-
tion, but relatively low magnitude ∆ψ (Fig. 7 B); (3) transport 
speed is increased if the steady-state ∆ψ is increased (Fig. 10); 
(4) transport effi ciency is decreased if the average ∆ψ is de-
creased (Fig. 6 A); (5) the fi rst ∆ψ requiring step can occur in 
the absence of precursor protein (Fig. 7 C); and (6) transport 
can be competitively inhibited long after transport initiation 
(Fig. 9). These fi ndings provide important constraints for the 
transport mechanism. Some of the implications are discussed in 
the following paragraphs.
A natural question to arise from these studies is whether 
the E. coli Tat transport system is fundamentally unique or dif-
ferent than the Tat transport system found in photosynthetic 
 organisms. Early in vitro studies in higher plant thylakoid systems 
support a picture wherein it is the ∆pH alone that provides the 
driving force for Tat precursor transport (Mould and Robinson, 
1991; Cline et al., 1992). More recent data suggest a minimum 
substrate-specifi c ∆pH (Alder and Theg, 2003). In contrast, 
in vivo studies in Chlamydomonas reinhardtii and barley leaves 
support a picture where it is the ∆ψ alone that provides the 
driving force for Tat precursor transport (Finazzi et al., 2003). 
Precursor maturation in tobacco protoplasts does not require either 
a ∆pH or a ∆ψ, but it is not clear whether the mature domain can 
be transported under these conditions (Di Cola et al., 2005). 
Possible explanations for the apparent discrepancies are that 
Figure 7 . Effect of the delayed addition of ionophores and pre-SufI on SufI 
transport effi ciency. All assays were conducted under standard transport 
 conditions (Fig. 1 C). (A) Effect of ∆pH collapse time on pre-SufI transport 
 effi ciency. This anti-SufI immunoblot shows the mean amount of pre-SufI trans-
ported when nigericin (10 μM) was added at various times after reaction initi-
ation (n = 3). The control lanes show the amount of pre-SufI transported after 
30 min in the presence (+) and absence (−) of NADH. Transport effi ciency 
was calculated based on the transport observed in the 30-min lane (lane 14). 
(B) Effect of PMF collapse time on pre-SufI transport effi ciency. This anti-SufI 
 immunoblot shows the mean amount of pre-SufI transported when both 
 nigericin (10 μM) and valinomycin (10 μM) were added at various times after 
reaction initiation (n = 3). The control lanes are the same as in panel A. 
(C) Effect of delayed pre-SufI addition on pre-SufI transport yield. This anti-SufI 
immunoblot shows the mean amount of pre-SufI transported when the pre-
cursor (50 nM) was added at various times after reaction initiation (n = 3). 
The control lane shows the amount of pre-SufI transported after 30 min in the 
absence of NADH. Transport effi ciency was calculated based on the transport 
observed when pre-SufI was present at the time of NADH addition (0 min).
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something is missing from in vitro assays and/or that both the 
∆ψ and the ∆pH can support Tat transport under certain condi-
tions (Theg et al., 2005). The hypothesis that both the ∆pH and 
∆ψ components of the PMF can energetically contribute to driving 
precursor transport is supported by recent in vitro studies in 
thylakoids (Braun et al., 2007). The studies reported here, how-
ever, raise some additional possibilities: (1) under some condi-
tions the ∆ψ is not completely collapsed by valinomycin alone; 
and (2) only a brief, yet relatively large, ∆ψ is necessary to initi-
ate a transport cycle. In thylakoids, a brief but substantial ∆ψ 
does exist upon photoillumination, which may be suffi cient to 
drive the fi rst step of Tat transport, and a relatively low ∆ψ does 
exist during steady state under in vivo conditions and under 
some in vitro conditions (Cruz et al., 2001), which may be suf-
fi cient to drive the completion of Tat transport.
According to current models, an early step in Tat transport 
is precursor binding to the TatBC complex. In some models, 
 recruitment of TatA molecules leads to formation of a highly 
selective pore that allows the precursor protein to cross the 
membrane (Palmer et al., 2005; Lee et al., 2006). In thylakoids, 
transport can occur without migration of the signal peptide from 
the TatBC binding site (Gerard and Cline, 2006). We show here, 
however, that transport was blocked by an excess of a precursor 
that was added many minutes after transport initiation. If trans-
port was inhibited by competitive binding, which seems likely, 
one interpretation is that the signal sequence binding interaction 
must be readily reversible. This conclusion is somewhat puz-
zling because it contradicts the thylakoid data, and because it 
would seem to lead to slow and ineffi cient transport. However, 
if different types of translocons existed (e.g., arising from dif-
ferent oligomeric states of TatA), a reversible signal sequence 
binding interaction on TatBC would be an effective way for the 
precursor to sample many different structures. One way that this 
could happen without losing the precursor to the bulk solution 
is if the signal peptide binds to the lipid alone, as has been 
recently demonstrated (Shanmugham et al., 2006). This picture 
could explain how spTorA-GFP can compete with pre-SufI for 
transport long after reaction initiation (Fig. 9). On the other 
hand, if multiple TatBC complexes can bind to the same TatA 
oligomer, multiple precursors could compete for translocation 
through the same gated pore. Hence, spTorA-GFP added after 
transport of pre-SufI has begun could bind to TatBC oligomers 
Figure 8. Effect of a second 𝚫𝛙 pulse on transport yield and transport kinetics at different IMV concentrations. All assays were conducted under standard 
transport conditions (Fig. 1 C), unless otherwise noted. (A) Effect of delayed addition of oxygenated buffer on transport yield. This anti-SufI immunoblot 
shows the mean amount of pre-SufI transported when the reaction volume was doubled with prewarmed (37°C) oxygenated buffer (35 μL; no NADH) at 
various times after reaction initiation in the presence of 8 mM NADH and 5 μM nigericin (n = 3). The control lane shows the amount of pre-SufI transported 
after 30 min in the absence of NADH. Note that the ordinate shows transport yield, i.e., the amount of precursor transported (in pmol) rather than the per-
centage of precursor transported relative to some control. [pre-SufI] = 250 nM; [IMV] = 2 (A280). (B) Generation of a second ∆ψ pulse at the indicated 
times (arrowheads) after the initial ∆ψ pulse. Time delays correspond to the points in panel A. Identical conditions as panel A. ∆F (100%) corresponds to 
the total fl uorescence observed at the beginning of the experiment (before NADH addition). (C) Kinetics of pre-SufI translocation at different IMV concentra-
tions, normalized to the 30-min time point. [pre-SufI] = 50 nM; [IMV] = 2 (black), 4 (red), and 6 (blue) (A280).
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that are a part of TatABC–pre-SufI complexes, and thereby re-
duce the effi ciency of pre-SufI transport. According to this pic-
ture, the signal sequence binding interaction could be relatively 
strong and not readily reversible, consistent with the thylakoid 
data that indicate that transport can occur without migration 
of the signal peptide from the TatBC binding site (Gerard and 
Cline, 2006).
There are at least two interpretations of the transport ki-
netics shown in Fig. 7 B. We discussed the single turnover cycle 
model in the Results section. According to this interpretation, 
a second turnover cycle cannot initiate without a second high-
magnitude ∆ψ pulse, and this pulse must occur at, or near, the 
end of the fi rst turnover cycle (compare Fig. 8 A with Fig. 7 B). 
An alternative interpretation is that each high-magnitude ∆ψ 
pulse is suffi cient to drive numerous turnover cycles. The initial 
lag in the observed kinetics would then be consistent with the 
hypothesis that the fi rst turnover cycle is relatively slow, and 
subsequent turnover cycles are faster. The existence of “slow” 
and “fast” enzymatic forms is not a novel concept (Shoji et al., 
2000). In contrast, as discussed earlier, if the translocons func-
tion with only one translocation speed under a given set of con-
ditions, then it is expected that higher translocon concentrations 
would yield faster overall translocation kinetics, which was not 
observed (Fig. 8 C). In conclusion, both the single and multiple 
turnover cycle models (with the slow and fast caveat for the 
latter) are consistent with our data.
The nature of the coupling between the ∆ψ and protein 
transport by the E. coli Tat machinery remains unclear. We have 
not ruled out the possibility that a concentration gradient other 
than the ∆pH is coupled to Tat transport—e.g., a sodium or 
other ion gradient. The coupling of ion fl ow to protein transport 
would imply that a portion of the energy stored in a potential gradi-
ent is “consumed” to drive transport because ion fl ow would 
 actually reduce the gradient. However, energy “consumption” 
is not strictly required. E. coli Tat protein transport occurs down 
a concentration gradient because precursor proteins are only 
found on the cytoplasmic side of the cytoplasmic membrane 
(the concentration of mature protein in the periplasm can be 
much higher, but this does not affect the thermodynamics of 
transport because these proteins cannot be transported after 
 signal peptide cleavage). Thus, instead of being consumed to 
energetically drive transport, it is possible that the ∆ψ is instead 
coupled to protein conformational changes (“gating reactions”) 
that are required for transport. In the case of voltage-gated ion 
channels, the membrane ∆ψ is coupled to the opening and clos-
ing of pores required for ion transport. Current models postulate 
that a charged region of voltage-gated ion channels moves in 
response to a ∆ψ, thereby causing the channel to open (Tombola 
et al., 2005). In the case of the Tat pathway, it is unlikely that the 
∆ψ would simply open large pores allowing folded proteins 
to diffuse across the membrane because this would result in 
the immediate collapse of the PMF and other ion gradients. 
However, a reasonable scenario is that movement of certain 
charged regions within Tat proteins could be induced by a ∆ψ. 
For example, the movement of ∆ψ sensing domains could lead 
to the oligomerization or rearrangements of subunits, leading 
the translocon to be primed and ready for catalyzing transport. 
We emphasize that this picture still requires additional gating 
re actions (e.g., signal peptide recognition) for controlling access 
to the translocation channel.
In summary, we have demonstrated an effi cient in vitro 
transport assay for the E. coli Tat machinery. When NADH was 
used to produce a PMF, transport was relatively slow and oc-
curred with a half-time of 10 min. Because faster transloca-
tion could be achieved with a higher magnitude and longer 
lasting PMF, we predict that in vivo transport rates are faster, 
and that our current transport rates are limited by the leakiness 
of IMVs. Nonetheless, under our conditions, precursor transport 
is ∆pH independent and there exist at least two ∆ψ-dependent 
transport steps.
Materials and methods
Bacterial strains, growth conditions, and plasmids
E. coli strains MC4100, MC4100∆TatABCDE, JM109, and BL21(λDE3) 
have been described earlier (Casadaban and Cohen, 1979; Yanisch-Perron 
et al., 1985; Studier et al., 1990; Wexler et al., 2000). Overexpression cul-
tures were grown in Luria-Bertani (LB) medium at 37°C supplemented with ap-
propriate antibiotics (Sambrook and Russell, 2001), unless otherwise noted.
The spTorA-GFP protein was expressed from plasmid pTorA-GFP. Plas-
mid pTorA-GFP was constructed by QuikChange site-directed mutagenesis 
(Stratagene) from pJDT1 (Thomas et al., 2001) using primers prTorAHis6C-F 
and prTorAHis6C-R as forward and reverse primers, respectively (Table S1, 
available at http://www.jcb.org/cgi/content/full/jcb.200702082/DC1). 
This process added a C-terminal HHHHHHC tag to the encoded protein.
The spSufI-GFP protein was expressed from plasmid pSufI-GFP, 
which was constructed in two steps by replacing the TorA signal peptide 
in pTorA-GFP with the SufI signal peptide. First, a unique SacII restriction 
 endonuclease site was generated 130 bp downstream of the translation start 
site encoding spTorA-GFP in pTorA-GFP by the QuikChange protocol using 
prTorA-ScII-F and prTorA-ScII-R as forward and reverse primers, respec-
tively (Table S1), generating plasmid pTorA-GFP2. Then, the PCR product 
generated from amplifi cation of pET-SufI (Yahr and Wickner, 2001) with 
Figure 9. Effect of delayed addition of spTorA-GFP on pre-SufI transport 
effi ciency. This anti-SufI immunoblot shows the amount of pre-SufI trans-
ported when spTorA-GFP (500 nM) was added at various times after re-
action initiation (n = 3). The control lanes show the amount of pre-SufI 
transported after 30 min in the presence (+) and absence (−) of NADH 
with no spTorA-GFP. Transport effi ciency was calculated based on the trans-
port observed in the +NADH control lane. All assays were conducted 
under standard transport conditions (Fig. 1 C).
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primers prSufI-sp-F and prSufI-sp-R (Table S1) was digested with EcoRI and 
SacII and inserted into pTorA-GFP2 digested with the same two restriction 
enzymes, generating plasmid pSufI-GFP. Coding regions were confi rmed 
by DNA sequencing.
Western blotting
TatA, TatB, and TatC were detected by Western blotting using rabbit 
 polyclonal TatA, TatB, and TatC antibodies (1:5,000 dilutions) (Yahr and 
Wickner, 2001) and GFP was detected by using rabbit polyclonal GFP anti-
bodies (1:10,000; Santa Cruz Biotechnology, Inc.) in 1× PBS (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4, pH 7.4) with 
2% nonfat dry milk, 0.1% Triton X-100, and 0.1% Tween. SufI was 
detected as described above by using rabbit 6xHis antibodies (1:1,000; 
Santa Cruz Biotechnology, Inc.), or by using SufI antibodies (1:15,000) 
(Yahr and Wickner, 2001) in 1× PBS as described above except with 
higher detergent concentrations (0.5% Triton X-100 and 0.5% Tween 20). 
Goat polyclonal anti–rabbit IgG-HRP conjugate (1:15,000; Santa Cruz 
Biotechnology, Inc.) was used as the secondary antibody, and bands 
were visualized by chemiluminescence (Harlow and Lane, 1999). Band 
intensities were quantifi ed with a PhosphorImager (model FX; Bio-Rad 
Laboratories).
Isolation of inverted membrane vesicles (IMVs)
Cells for IMV isolation were grown in low-salt LB medium (1% bactotryp-
tone, 0.5% yeast extract, and 0.25% NaCl) supplemented with 5% glyc-
erol. Overnight cultures were subcultured (1:100; 4 × 750 ml) and grown 
at 37°C for 3–4 h until the A600 reached 1. TatABC expression from 
pTatABC (Yahr and Wickner, 2001) was induced with 0.7% arabinose 
and growth was continued for another 4 h. Cultures were plunged into an 
ice bath and cells were harvested by centrifugation at 4,000 g for 8 min 
at 4°C. The cell pellet (10–12 g) was suspended in 50 ml ice-cold Buffer A 
(1 mM MgSO4, 0.5% polyvinylpyrrolidine [MW 360,000], 450 mM 
mannitol, 2 mM DTT, 50 μg/ml DNase I, 10 μg/ml RNAase, 1 mM KCl, and 
100 mM Tricine, pH 7.5) with 0.4 mg/ml lysozyme, 0.5 mM EDTA, and 
protease inhibitors (10 mM PMSF, 100 μg/ml trypsin inhibitor, 20 μg/ml 
leupeptin, and 100 μg/ml pepstatin), and incubated on ice for 20 min to 
produce spheroplasts. The spheroplasts were sedimented by centrifugation 
at 4,000 g for 10 min at 4°C, resuspended in Buffer A, and passed through 
a French pressure cell once at 6,000 psi to produce IMVs. The IMV solu-
tion was centrifuged at 4,000 g for 10 min at 4°C to remove debris. 
The supernatant (8-ml portions) was layered over 6-ml sucrose cushions 
(Buffer B [1 mM KCl, 1 mM MgSO4, 2 mM DTT, and 10 mM Hepes, pH 7.0] 
with 2.2 M sucrose) and centrifuged for 75 min at 108,000 g. The band 
from the top of the sucrose cushion in each tube was collected. IMVs were 
pooled, diluted 1:4 with Buffer B, and centrifuged for 45 min at 108,000 g. 
The pellet was resuspended in 4–6 ml of Buffer B with 50% glycerol, and 
frozen immediately at −80°C. Total protein was quantifi ed as the A280 in 
2% SDS. Typical IMV stock solutions had an A280 ≈ 50–60.
Protein expression and purifi cation
Pre-SufI was overexpressed from pET-SufI (Yahr and Wickner, 2001) in 
BL21(λDE3) and purifi ed under native conditions by Ni-NTA chromatogra-
phy. LB cultures (500 ml) were incubated at 37°C until the A600 reached 
3. The pH of the cultures was raised with 25 ml of 0.5 M CAPS buffer 
(pH 9.0), and induced with 0.5 mM IPTG for 2.5 h. Cultures were chilled 
in an ice bath and centrifuged at 5,000 g for 8–12 min at 4°C. Pellets 
were rapidly resuspended on ice in 50 ml Buffer C (100 mM Tris and 
25 mM CAPS, pH 9.0) containing 250 mM NaCl, 20 mM imidazole, 
0.2% Triton X-100, and protease inhibitors. Cells were then passed through 
a French pressure cell once at 16,000 psi. The cell lysate was cleared of 
cellular debris by centrifugation at 50,000 g for 10 min at 4°C, and then 
stirred with 2 ml Ni-NTA Superfl ow resin (QIAGEN) that had been pre-
equilibrated with Buffer C for 10 min on ice. The resin was loaded onto a 
10 × 1 cm column, and sequentially washed with: (1) 100 ml of Buffer D 
Figure 10 . Effect of ATP on pre-SufI transport. (A) Generation of ∆pH by ATP. IMVs (A280 = 5) were energized with 4 mM NADH (black) or 4 mM ATP + 
 regenerating system (red). The ATP-induced ∆pH was collapsed by 5 μM nigericin (blue). ATP regenerating system: 2.9 mM phosphocreatine, 0.29 mg/ml 
creatine kinase. (B) Generation of ∆ψ by ATP. IMVs (A280 = 5) were energized with 4 mM NADH (black) or 4 mM ATP + regenerating system (red). 
The ATP-induced ∆ψ was collapsed by 25 mM NaSCN (blue). Note that the fi nal baseline is signifi cantly higher in the presence of ATP than NADH due to a 
 direct effect of NADH on the fl uorescence emission yield of oxonol VI (compare with the traces in Fig. 4 B in the presence of ionophores). (C) Effect of ATP 
on pre-SufI transport kinetics. This anti-SufI immunoblot shows the mean amount of pre-SufI transported as a function of time when the PMF was generated 
by 4 mM ATP + regenerating system (n = 3). (D) Effect of selective gradient collapse on pre-SufI transport effi ciency using ATP to generate a PMF. The same 
experiment as Fig. 6 B using 4 mM ATP + regenerating system instead of NADH.
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(10 mM Tris-HCl, 1 M NaCl, and 20 mM imidazole, pH 8.0) with 0.1% 
Triton X-100; (2) 20 ml of Buffer D; (3) 20 ml of 100 mM NaCl and 10 mM 
imidazole, pH 8.0; and (4) 10 ml of 100 mM NaCl, 10 mM imidazole, 
and 50% glycerol, pH 8.0. Pre-SufI was eluted with 100 mM NaCl, 250 mM 
imidazole, and 50% glycerol, pH 8.0 as 1-ml fractions and stored at −80°C. 
Typical yield was 8–10 mg protein/L of culture.
The spSufI-GFP and spTorA-GFP proteins were overexpressed from 
plasmids pSufI-GFP and pTorA-GFP, respectively, in MC4100∆TatABCDE. 
These GFP proteins were purifi ed under denaturing conditions and re-
folded by dilution/dialysis from 9 M urea. Overnight LB cultures with 1% 
glucose were subcultured into fresh LB medium with 1% glucose (1:100 di-
lution; 3 × 500 ml) and grown at 37°C until the A600 reached 5 (4 h). 
Cells were harvested by centrifugation, resuspended in fresh LB medium 
with 1.5% arabinose to induce protein expression, and incubated at 37°C 
for 2.5 h. Cells (7 g) were harvested by centrifugation, resuspended in 
50 ml Buffer E (20 mM CAPS, 2 mM DTT, and 0.2% Triton X-100, pH 9.0) 
with protease inhibitors, and stirred on ice for 30 min. The cell suspension 
was passed through a French pressure cell once at 16,000 psi. The cell 
lysate was diluted to 400 ml with Buffer E, and centrifuged at 15,000 g for 
30 min. Pellets containing inclusion bodies were suspended in Buffer F 
(10 mM CAPS, 5 mM DTT, and 9 M urea, pH 9.0), and stirred at room temper-
ature (RT) for 30 min. The resuspension was centrifuged at 50,000 g for 
30 min. The supernatant was stirred with 4 ml Ni-NTA Superfl ow resin 
equilibrated with Buffer F for 30 min at RT, and then loaded onto a 10 × 
1 cm column. The resin was washed sequentially with: (1) 20 ml Buffer F; 
(2) 20 ml Buffer F with 0.1% Triton X-100; and (3) 10 ml Buffer G (50 mM 
MOPS, 9 M urea, 100 mM KCl, 10% glycerol, 5 mM Mg acetate, 50 mM 
glycine-glycine, and 5 mM DTT, pH 8.0) with 10 mM imidazole. Proteins 
were eluted with Buffer G with 250 mM imidazole. Protein concentration 
was quantifi ed using ε280 = 2.06 × 104 M−1 cm−1 (Enoki et al., 2004), 
and solutions were diluted to 50 ng/ml with Buffer G. Proteins were folded 
by dialyzing (10 kD molecular weight cut-off) out the urea using a four-step 
gradient (9 M → 7 M → 5 M → 3 M; 3 h per step) in the dark (typical 
yield was 95–99% folded protein). The dialyzate was centrifuged at 
15,000 g for 30 min. Folded protein was recovered from the supernatant 
using 5 ml Ni-NTA Superfl ow resin equilibrated with 50 mM MOPS, 
100 mM KCl, 5 mM Mg acetate, and 5 mM DTT, pH 8.0. The Ni-NTA–
adsorbed GFP proteins were washed and eluted identically as described 
above for the purifi cation of pre-SufI. Typical yield was 2 mg protein/L 
of culture.
Protein concentrations of all Tat substrates were quantifi ed by SDS-
PAGE using bovine serum albumin (BSA) as the standard and quantifi ed 
with a PhosphorImager (model FX; Bio-Rad Laboratories).
In vitro translocation assay
Standard in vitro translocation assays used a 35-μl reaction volume con-
taining 50 nM pre-SufI and 4 mM NADH in Translocation Buffer (TB; 5 mM 
MgCl2, 50 mM KCl, 200 mM sucrose, 57 μg/ml BSA, 25 mM MOPS, and 
25 mM MES, pH 7.0). Solutions were prewarmed at 37°C for 5 min  before 
the addition of IMVs (to a typical fi nal concentration of A280 = 5). After 
a 30 min incubation at 37°C, reactions were quenched in an ice bath for 
2 min. Samples were digested with 0.73 mg/ml proteinase K for 40 min 
at RT. Digestions were quenched with 68 mM PMSF, diluted twofold with 
2× Gel Buffer (4% SDS, 10% glycerol, 0.04% bromophenol blue, 0.4% 
β-mercaptoethanol, 10 M urea, and 200 mM Tris, pH 6.8), and incubated 
in a boiling water bath for 10 min. Samples were centrifuged briefl y at 
16,000 g, and then were resolved by 8% SDS-PAGE with known standards. 
Gels were electroblotted onto PVDF membranes and immunoblotted with 
SufI antibodies. For spSufI-GFP and spTorA-GFP translocation assays, 
both protease-treated and untreated IMVs were sedimented at 100,000 g 
at 4°C for 15 min (or 16,100 g at 4°C for 45 min). The IMVs (pellets) were 
washed with 500 μl TB with 20 μg/ml BSA, resuspended in 35 μl TB con-
taining 68 mM PMSF, resolved by 10% SDS-PAGE with known standards, 
and immunoblotted using GFP antibodies.
The sidedness of IMV preparations
The TatB protein has a single transmembrane domain near the N terminus 
and a C-terminal cytoplasmic domain (Berks et al., 2000). TatB is unlikely 
to undergo topology inversion (Bolhuis et al., 2001), as has been reported 
for TatA (Gouffi  et al., 2004; Chan et al., 2007). The percentage of IMVs 
with an inside-out orientation was determined based on the protease 
 accessibility of the TatB C-terminal domain using TatB antibodies raised 
against peptides within this domain (Yahr and Wickner, 2001). IMVs in TB 
without BSA were incubated with 2 mg/ml proteinase K at RT for 30 min. 
Digestions were quenched with 20 mM PMSF, diluted twofold with 2× Gel 
Buffer, and incubated in a boiling water bath for 10 min. Samples were 
centrifuged briefl y at 16,000 g, and then were resolved by 18% SDS-
PAGE with known standards. Gels were electroblotted onto PVDF mem-
branes and immunoblotted with TatB antibodies.
Determination of 𝚫pH and 𝚫𝛙 gradients
The presence of ∆pH and ∆ψ gradients across IMV membranes was deter-
mined by fl uorescence spectroscopy using 2.5 μM quinacrine (EX = 420 nm, 
EM = 510 nm) and 100 nM oxonol VI (EX = 610 nm, EM = 645 nm), 
respectively (Kawasaki et al., 1993). IMVs were preincubated in TB at 
37°C for 5 min before the addition of 4 mM NADH or 4 mM ATP. Condi-
tions were identical to those used for gel-based transport assays. Control 
experiments indicated that the effects observed when ionophores were 
added were not due to dilution or solvent.
Data analysis
All errors are standard deviations.
Online supplemental material
Table S1 summarizes the DNA primers used for plasmid construction. Fig. S1 
shows the effect of IMV formation method and transport buffer on transport 
effi ciency. Fig. S2 shows the transport effi ciency dependence on energy 
source. Fig. S3 shows the effect of high valinomycin concentration on 
∆pH and ∆ψ. Online supplemental material is available at http://www
.jcb.org/cgi/content/full/jcb.200702082/DC1.
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